AllSeeing is revolutionizing skin cancer diagnosis by repurposing its high-resolution imaging RADAR, made as a lunar-gateway sensor, into a non-invasive inner tissue imager. Unlike dermatologist visual inspection and biopsies, our technology provides early, fast, accurate, reliable, and pain-free tissue diagnostics, without the risk of disfigurement or scarring via spectrum imaging. 30% of diagnosed cancer is skin related, as such, our solution aids the early-stage care of millions of patients.
We are a health technology company that specializes in the prevention, assessment and management of mental health disorders. Our main goal is to help people and organizations to achieve their full potential. We embraces the importance of an early and accurate diagnosis, that leads to personalized treatments, and facilitates functional recovery. We developed the EarlyDetect technolgy to facilitate precision mental health diagnosis and prevention.
Conlis Global Inc.
Conlis Global Inc.
Conlis Global Inc. is a Canadian company that aims to revolutionize regenerative medical solutions for bone, cartilage, skin, and liver. Its transformative innovations have the potential to reshape contemporary transplantation and surgical practices, setting new standards of excellence.
Crocus Biomedical is a University of Calgary-based startup that has developed a blood and tumour tissue-based molecular test for physicians to identify individuals at high risk of bone metastasis.
Heros Biotech is developing the most advanced and accessible early cancer detection test for companion animals.
LitLife harnesses AI to redefine wellness journeys- addressing the barrier of personalized fitness and nutrition guidance by offering an AI-powered trainer, Chiron. Chiron provides personalized workout and dietary plans while ensuring proper form during exercises, using real-time data and machine learning.
Naiad Lab Inc.
Naiad Lab Inc.
MedROAD provides an advanced data analytics-driven virtual clinic for effective monitoring of the general public to contain the COVID-19 spread and flatten the curve. We have centralized and integrated the tool for the public to receive personalized oversight by health professionals for their health status. MedROAD expedites the management of assessment, triage, and monitoring. MedROAD enables data gathering, feedback, and reporting to health organizations for efficient tracking of COVID-19.
Qubit Sense Inc.
Qubit Sense Inc.
Expedite drug discovery and creation using quantum computing.
Medical imaging – the ability to see inside the body – has revolutionized patient care, but is only available in large tertiary hospitals and specialty clinics in big cities. Sonance believes imaging should be available to every patient, everywhere. Ultrasound — safe, non-invasive, and inexpensive — can accomplish that mission. With the help of modern hardware, AI, and cutting edge software, Sonance is bringing the promise of medical imaging to the smallest and most remote medical clinics.
It’s a food diary app for those struggling with IBD. It records the meals you eat to the symptoms you may be experience, and correlates your symptoms to your food diary. IBD is very difficult to manage because each person has their own unique triggers, so this app can help ease your experiences with IBD.
Patrick van Gelder
Director of Marketing, Bioventus
“The most exciting aspect of API’s Life Sciences Venture Coaching Program for me is to be able to share my experiences and insights to support the growth of organizations and individuals in the sector. I have been blessed with the guidance of some incredible mentors throughout my career and having opportunities to engage with aspiring individuals and companies is my way to pay it forward.”
Patrick van Gelder is the Director of Marketing, International Markets at Bioventus. He is a results-oriented professional with decades of experience in business transformation, turnarounds and start-ups in medical technology, vaccine, and pharmaceutical businesses. In addition, Pat possesses extensive expertise in sales, marketing, finance, government relations, and global operations in Canada, the USA and the European Union. He is a University of Alberta alumni with a Bachelor of Education in History and Biology.
Global Product Manager, Sartorious Stedim Biotech
“Helping organizations to establish, grow and succeed is my passion. I am thankful for the opportunity to connect with companies at the early stage of their development and to help them navigate through the various hurdles that they will encounter. API’s Life Sciences Venture Coaching program is a great vehicle to help startups manage the bumps in the road that lies ahead.”
Jalil Hakimi is a visionary biotech and pharmaceutical professional with more than 20 years of experience in research and development for Sanofi Pasteur, establishing and managing the core facilities for the Sunnybrook Research Institute, and the University Hospital Network.
Currently, he is the Global Product Manager for Sartorius Stedim Biotech and a board member of the QCare Health Group. Jalil is passionate about next-generation medicine, advanced therapies, and cell immunotherapy, and has been recognized for his distinctive mentoring and coaching skills. He holds an Undergraduate Degree in Medical Laboratory Sciences from the Babol University of Medical Sciences, a Postgraduate Degree in Biotechnology from the University of Toronto, and an Executive MBA from the Ivey Business School at Western University.
Director of Industry and Investment Relations, EXCITE International
“Throughout my career, I have been a strong advocate for innovation and commercialization of products that have a real impact on patients, whether it was through my work at an industry association or at a biotech company involved in treating rare diseases. Participating in API’s Life Sciences Venture Coaching program is an opportunity to support the people and organizations with dreams of making a difference in the life sciences.”
Brian Lewis is the former President and CEO of Medtech Canada and Country General Manager, Sanofi Genzyme. His passion is helping medical technology innovators succeed in the quest for fast, efficient, cost-effective adoption of innovations, and maximization of financial performance. Currently, he is the President of Brian Lewis and Associates Inc. and also the Director of Industry and Investor Relations at EXCITE International, a not-for-profit focused on de-risking investment of breakthrough technologies and accelerating the global adoption of non-drug health technologies. He holds a Bachelor of Science from the University of Guelph and a Bachelor of Business Administration from York University.
Digital Transformation Leader
“I am passionate about the impact of digital technology in all forms and its potential applications in the life sciences sector. I am looking forward to meeting the various companies in the API Life Sciences Venture Coaching program, and to provide any kind of advice and assistance to help start-up companies succeed.”
Elodie Martin is a Digital Transformation and Omnichannel Engagement Consultant. She is an experienced pharma professional in digital transformation strategy with a proven track record of successfully leading complex projects and driving change in a highly regulated environment. Her experience in regulatory and medical affairs ensures that regulatory constraints and compliance considerations are always on their radar. Elodie has over a decade of experience in regulatory affairs, business planning and strategy in Pharmascience, Sanofi, Hospira, and more. She holds a Bachelors of Biology from McGill University and a Masters in Molecular Biology from Université de Montréal.
“Our ability to innovate and move from startup to commercialization is key to build a strong Canadian Life Sciences Ecosystem. Coaching a startup is a way to contribute to this mission while discovering new technologies, partnering with a highly motivated team, and ultimately improving healthcare and patients’ outcomes.”
Nicolas Petit is a biotech executive with 15+ years’ experience in pharma, vaccines, and biotech with a focus on commercial operations, corporate development and external affairs. Until recently, he was the Vice President, Commercial Operations at Medicago. He spent a decade at Sanofi in Commercial Operations and Business Development positions across five different countries. He is also the Director at BioQuebec since 2021. He holds a Master degree in Agronomy and Life Sciences from ENSAIA School in France, and an Advanced Master Degree in International Management from ESSEC Business School.
Solomon Ssenyange, PhD
CEO, RedNOX Inc.
“I had such great experience attending the University of Alberta and living in Edmonton for several years. I would like to see the life sciences ecosystem in Alberta thrive and through the API Venture Coaching program, I’ll serve as a coach for start-ups as a serial entrepreneur with a successful exit. There are a lot of real-world experiences to share with future and current budding entrepreneurs in the hardware and medical technology space.”
Solomon Ssenyange, PhD is an experienced serial entrepreneur. He is the former CEO of Spirosure Inc., co-founder and former CEO of Single Helix Genomics and Silvertip Medical, Inc., and is the current co-founder of RedNOx, Inc. Solomon developed a sensor that can diagnose asthma and COPD via a nitric oxide biomarker in exhaled breath at Spirosure, a diagnostics startup which was later acquired. He is using the same technology for his current venture RedNox Inc., where he is building sensors for emission detection. He holds a Bachelor of Sciences from the University of Manitoba, and a PhD in Analytical Chemistry from University of Alberta.